ÂÜÀòÂÒÂ×

Dr. Miller brings over two decades of pharmaceutical development experience and has spent his career investigating ways to improve the bioavailability enhancement of poorly soluble molecules. As CSO of AustinPx, Dr. Miller leads the pharmaceutics and analytical development teams and oversees the application of the KinetiSol® Technology. Prior to joining AustinPx, Dr. Miller was a senior principal scientist at Hoffmann-La Roche, Inc. His expertise includes amorphous formulation technologies, solid dispersions, solubility enhancement, KinetiSol dispersing, hot-melt extrusion, spray drying, particle engineering, non-sink dissolution testing methodologies, establishing in-vitro/in-vivo relationships, solid state characterization, physical stability assessment of amorphous systems and final dosage form design. Dr. Miller earned his BS in Chemical Engineering and his PhD in Pharmaceutics from the University of Texas at Austin. His doctoral research was conducted under the supervision of Professors James W. McGinity and Robert O. Williams III. Dr. Miller has published numerous peer-reviewed research articles, authored several book chapters, filed multiple patent applications and is a co-editor of the book Formulating Poorly Water-Soluble Drugs.